GLCCI1 and asthma: In summary, the GLCCI1 (rs37973 G > A) variant affects the efficacy of ICS in the treatment of asthma, and the results of this study provide a theoretical basis for the use of the rs37973 variant as a predictor of the efficacy of ICS in asthma patients.